Home-grown FMCG major Dabur has lowered the time of its strategic vision cycle from four years to three years aiming to create a more agile organisation amid a slowdown in the FMCG space and volatile geopolitical landscape. It has engaged consulting firm McKinsey & Co to refine and align its strategies for the next three years in line with the evolving dynamics, its CEO Mohit Malhotra said in an earnings call. "This exercise has already begun, and we plan to conclude the same by the end of the fiscal year. This will enable us to capture emerging opportunities and navigate the future with sharper and more focused vision," he said. Dabur has four-year vision plans and is currently in the seventh vision cycle. "Earlier we used to have a four-year vision cycle... We feel that in this volatile and heavy-headwind macroeconomic environment and FMCG not doing so well as a sector... we require a validation of our strategies through an external consultant," he said. Malhorta further said ..
FMCG major Dabur has become the second-largest player in the oral care segment in the modern trade channels, its chief executive officer Mohit Malhotra claimed on Monday. The company, which operates in the segment with Dabur Red Toothpaste and premium brand Meswak, ended the quarter with a 9.1 per cent growth and it believes that this segment has " huge potential". "The Gel toothpaste portfolio has received a good response, recording 50%+ y-o-y growth this quarter. Dabur oral care is now the 2nd brand in Modern Trade Pan-India," he said in the post-earnings call. "Even in modern trade, where the competitor is very strong with premium variants etc., there also we have become a number two brand now in modern trade. So, this is very encouraging for us," Malhotra added. The oral care market is led by Colgate Palmolive and FMCG major HUL is at the second spot with brands such as Pepsodent, Closeup and Ayush. "Dabur Red is doing well on the back of tailwind coming from the herbal catego
Company record net profit of Rs 522 crore, revenue rises 3.1% in Q3
Homegrown FMCG major Dabur India Ltd on Thursday reported a 1.85 per cent increase in consolidated net profit to Rs 515.82 crore in the December quarter. The company had posted a net profit of Rs 506.44 crore in the year-ago period, Dabur India said in a regulatory filing. Its revenue from operations was up 3 per cent to Rs 3,355.25 crore during the quarter under review. It was Rs 3,255.06 crore in the corresponding quarter of the previous fiscal year. Dabur India's total expenses were at Rs 2,826.20 crore, up 3.9 per cent in the December quarter. Total income of Dabur, which includes other income, was at Rs 3,483.28 crore, up 3 per cent. Shares of Dabur India Ltd were trading at Rs 535.10 on the BSE after lunch session, up 3.27 per cent from the previous close.
Schezwan Chutney: Brand name or generic product? Delhi High Court is hearing arguments from Dabur India and Tata Consumer-owned Capital Foods
The upcoming Union Budget is the near-term catalyst, where central government actions to revive consumption cycle would be key.
Technical chart shows that the Nifty Next 50 index looks weak and could slide towards 58,670 - implying an over 11% fall from present levels, whereas on the upside can jump by 6% to 70,200 levels.
Many analysts have downgraded growth and margin expectations in response to the update
Union Bank stock futures plunged nearly 8% on the back of 54% increase in OI. On the other hand, Dr. Lal Path Labs and Metropolis Health witnessed long build-up on Monday; shows derivatives data.
The maker of Hajmola candy and Real fruit juice said rural consumption continued to be resilient and grow faster than urban in the third quarter
Dabur expects a "low single-digit growth" in the December quarter along with a "flattish operating profit" as the homegrown FMCG major faced inflationary headwinds in some of the segments. This forced Dabur to go for "tactical price increases" and tried to mitigate the inflationary pressure through cost-efficiency initiatives partially, Dabur informed in its quarterly updates on Friday. During the October-December period, rural consumption of FMCG was resilient and continued to grow faster. Alternative channels like modern trade, e-commerce, and quick commerce continued to post strong growth, while general trade, which mainly includes neighbourhood kirna stores was still under pressure in the October-December period. In the domestic market, Dabur's HPC (home & personal care) is expected to grow in the mid to high single digits, while Health Care is expected to be 'flattish' due to the delayed winter onset. "While the Beverages portfolio is expected to report muted performance, our
The lawsuit alleges that an advertisement featuring Patanjali Ayurved founder Baba Ramdev falsely claims that only Patanjali's Chyawanprash is 'original'
Dabur is expanding its premium portfolio and Total Addressable Market (TAM). The company estimates its existing portfolio, contributes less than 5 per cent of TAM
As FMCG shares led by Godrej Consumer fell up to 11% on Monday post the volume growth concern; the Nifty FMCG index slipped below its 20-DMA after a two-week struggle; chart hints at further 4.5% dip.
Dabur India faces a Rs 4.42 crore tax demand from Customs for IGST on imports from 2019-2024; the FMCG firm plans to appeal, citing strong merits for a favourable outcome
India revenue declined 7.6 per cent Y-o-Y, while international business grew 13 per cent Y-o-Y in constant currency (CC) terms
The maker of Hajmola candy and Real fruit juice, recorded a 5.5 per cent drop in net sales to Rs 3,028.6 crore from Rs 3,203.8 crore in the year ago period
Homegrown FMCG major Dabur India Ltd on Wednesday reported a decline of 17.65 per cent in its consolidated net profit to Rs 417.52 crore in the September 2024 quarter. The company had posted a net profit of Rs 507.04 crore in the July-September quarter a year ago, Dabur India said in a regulatory filing. Its revenue from operations slipped 5.46 per cent to Rs 3,028.59 crore during the quarter under review. It was Rs 3,203.84 crore in the corresponding quarter of the previous fiscal. Dabur India's total expenses were at Rs 2,634.40 crore, down 1.31 per cent in the September quarter. "Despite a challenging demand environment marked by high food inflation and a resultant squeeze in urban demand, Dabur continued to drive consumer engagement across its key brands to end the second quarter of 2024-25 with a consolidated revenue of Rs 3,029 crore," Dabur said in its earnings statement. Shares of Dabur India Ltd settled 2.07 per cent higher at Rs 546.95 on the BSE.
Home-grown FMCG and Ayurvedic products maker Dabur on Wednesday announced the acquisition of Sesa Care, engaged in the Ayurvedic personal care and wellness segment, at an enterprise value of Rs 315-325 crore. This new acquisition will help Dabur to expand in the Rs 900 crore ayurvedic hair oil market, the company said in a regulatory filing. It has entered into an agreement to acquire the majority 51 per cent stake from its shareholder True North (a private equity fund) for Rs 12 crore at face value. "The enterprise value is estimated to be in the range of Rs 315-325 crore, including debt of Rs 289 crore, which will be backed by the corporate guarantee of Dabur," it added. While the remaining 49 per cent shares in Sesa, there will be a share swap for the equity shares. "The share swap for the equity shares and remaining 49 per cent CRPS in Sesa will be decided at the time of filing the scheme of merger, based on the valuation reports," it said. This merger aligns with Dabur's ...
Q2FY25 company results: Aditya Birla Capital, Protean eGov Technologies, TTK Prestige, and New India Assurance will release their second-quarter results for the financial year 2024-25 on October 30